Hemodynamic improvement of acutely decompensated heart failure patients is associated with decreasing levels of NT-proBNP

International Journal of Cardiology

Volumn 134, Issue 2, 2009, Pages 260-263

  Knebel, Fabian ^a   Schimke, Ingolf ^a   Diaz Ramirez, Ivan ^a   Schattke, Sebastian ^a   Eddicks, Stephan ^a   Borges, Adrian C ^a   Baumann, Gert ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Acute heart failure; Intensive care; Invasive hemodynamics; Natriuretic peptides; NT proBNP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; DIURETIC AGENT; INOTROPIC AGENT; VASODILATOR AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART INDEX; HEART STROKE VOLUME; HEMODYNAMICS; HUMAN; LUNG WEDGE PRESSURE; MALE; PRIORITY JOURNAL;

ACUTE DISEASE; BIOLOGICAL MARKERS; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS;

EID: 67349108348     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.12.106     Document Type: Article

References (19)

1. Hedberg P., Lonnberg I., Jonason T., Nilsson G., Pehrsson K., and Ringqvist I. Left ventricular systolic dysfunction in 75-year-old men and women; a population-based study. Eur Heart J 22 8 (2001) 676-683
2. Stewart S., MacIntyre K., Hole D.J., Capewell S., and McMurray J.J. More 'malignant' than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail 3 3 (2001) 315-322
3. Connors Jr. A.F., Speroff T., Dawson N.V., et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA 276 11 (1996) 889-897
4. Gnaegi A., Feihl F., and Perret C. Intensive care physicians' insufficient knowledge of right-heart catheterization at the bedside: time to act?. Crit Care Med 25 2 (1997) 213-220
5. de Lemos J.A., McGuire D.K., and Drazner M.H. B-type natriuretic peptide in cardiovascular disease. Lancet 362 9380 (2003) 316-322
6. Bettencourt P.M. Clinical usefulness of B-type natriuretic peptide measurement: present and future perspectives. Heart 91 11 (2005) 1489-1494
7. Januzzi J.L., van Kimmenade R., Lainchbury J., et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 27 3 (2006) 330-337
8. Wu A.H., Harrison A., and Maisel A.S. Reduced readmission rate for alternating diagnoses of heart failure and pulmonary disease after implementation of B-type natriuretic peptide testing. Eur J Heart Fail 6 3 (2004) 309-312
9. Kazanegra R., Cheng V., Garcia A., et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. J Card Fail. 7 1 (2001) 21-29
10. Bettencourt P., Azevedo A., Pimenta J., Frioes F., Ferreira S., and Ferreira A. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 110 15 (2004) 2168-2174
11. Logeart D., Thabut G., Jourdain P., et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 43 4 (2004) 635-641
12. Troughton R.W., Frampton C.M., Yandle T.G., et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 355 9210 (2000) 1126-1130
13. Sokoll L.J., Baum H., Collinson P.O., et al. Multicenter analytical performance evaluation of the Elecsys proBNP assay. Clin Chem Lab Med 42 8 (2004) 965-972
14. O'Neill J.O., Bott-Silverman C.E., McRae III A.T., et al. B-type natriuretic peptide levels are not a surrogate marker for invasive hemodynamics during management of patients with severe heart failure. Am Heart J 149 2 (2005) 363-369
15. Tung R.H., Garcia C., Morss A.M., et al. Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock. Crit Care Med 32 8 (2004) 1643-1647
16. Lainchbury J.G., Campbell E., Frampton C.M., Yandle T.G., Nicholls M.G., and Richards A.M. Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol 42 4 (2003) 728-735
17. Wu A.H., Smith A., Wieczorek S., et al. Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol 92 5 (2003) 628-631
18. Wu A.H., and Smith A. Biological variation of the natriuretic peptides and their role in monitoring patients with heart failure. Eur J Heart Fail 6 3 (2004) 355-358
19. Anwaruddin S., Lloyd-Jones D.M., Baggish A., et al. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coll Cardiol 47 1 (2006) 91-97